(ZLAB) – PRNewswire
-
Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange
-
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
-
Qiming's Portfolio Company InventisBio Lists on STAR Market
-
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
-
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List
-
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market
-
Qiming's Portfolio Company Arrail Group Lists on Main Board of HKEX
-
Qiming Venture Partners Welcomes David Chu as IR Partner
-
Qiming Venture Partners Announces Annual Promotions
-
Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team
-
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx
-
Qiming's Portfolio Company Aohua Endoscopy Lands on STAR Market
-
Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
-
Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx
-
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx
-
Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D
-
Qiming's Portfolio Company Broncus Lists on Main Board of HKEx
-
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market
-
Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market
-
Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China
-
Qiming's Portfolio Company Fanli.com Goes Public on Shanghai Stock Exchange
-
Qiming's Duane Kuang, Nisa Leung Named on 2021 Forbes Midas List
-
Qiming's Portfolio Company Zhihu Lists on New York Stock Exchange
-
Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq
-
First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts
-
Qiming Venture Partners Closes RMB Fund VI at RMB 2.852 billion
-
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange
-
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX
-
Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII
-
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million
-
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX
-
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
-
Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board
-
Qiming's Portfolio Company SinocellTech Lands on STAR Market
-
Regeneron Reports First Quarter 2020 Financial and Operating Results
-
Qiming's Nisa Leung and Duane Kuang Named on 2020 Forbes Midas List
-
Qiming Venture Partners Raises $1.1 Billion Fund VII
-
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)
-
Qiming's Portfolios Fight the Novel Coronavirus
Back to ZLAB Stock Lookup